Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CLINICAL CORNER: New-Gen Bariatric Devices Show Promise With Positive Data

This article was originally published in Clinica

Executive Summary

Bariatric medicine for managing obesity and type 2 diabetes has advanced beyond surgical gastric bypass and gastric banding. The annual Digestive Disease Week (DDW) meeting in May highlighted a move towards novel minimally invasive technologies that do not require incisions, and others that do not even require endoscopic placement of the device. Highlights of the meeting include the clinical trial results from three promising technologies: GI Windows' Incisionless Anastomosis System, Allurion Technologies' Elipse Gastric Balloon, and Obalon Therapeutics' Obalon Gastric Balloon System

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103505

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel